Archive · 17 Jun 2025
India's Pharma Market Sees 6.9% Growth in May
India's pharmaceutical market is doing well!
It grew almost 7% in May, especially due to the sales of medicines for long-term conditions and diseases.
Indian companies saw growth, along with international ones.
While medicines for short-term illnesses didn't grow as much, the overall market continues to expand.
The Indian pharma industry is large and is expected to keep growing, providing lots of affordable medicines worldwide.
India's pharma market grew 6.9% in May, driven by specific therapies.
Indian companies grew 6.6%, while MNCs grew 8.4% YoY in May.
Acute therapy growth was muted at 5% in May.
For the 12 months ending May, IPM growth was from price, new launches, and volume increases.
Chronic therapies saw 10% YoY growth in May.
- Who
- The India pharma market.
- What
- The Indian pharma market grew by 6.9% in May, driven by strong performance in specific therapies.
- When
- In May.
- Where
- India.
- Why
- Due to strong demand and new products.
- Market Growth (May)
- 6.9% YoY
- Indian Companies Growth (May)
- 6.6% YoY
- MNCs Growth (May)
- 8.4% YoY
- Acute Therapy Growth (May)
- 5% YoY
- Chronic Therapies Growth (May)
- 10% YoY
- Industry Rank (Volume)
- 3rd globally
Sources
India continues to lead as global vaccine supplier, generic drug manufacturer: Anupriya Patel
70% vaccines sourced by WHO, 14% generics imported by US are from India: Minister
India supplies 70% of WHO vaccines, says Anupriya Patel; Calls for regulatory harmony to boost global health equity